 The agency has approved the treatment, which will be sold under the brand name Kisunla for adults in early stages of the illness. Nearly 7 million Americans have the condition, and it is the fifth leading cause of death for adults over 65. The stock market is closed for the holiday today and will reopen tomorrow. That's your Money Now.